* Propanc Biopharma (OTCPK:PPCB [https://seekingalpha.com/symbol/PPCB]) priced a public offering of 1M shares at $4 each, expecting $4M in gross proceeds to fund working capital and general purposes.
* In connection with the offering [https://seekingalpha.com/pr/20202252-propanc-biopharma-announces-nasdaq-uplisting-and-pricing-of-4-million-public-offering], the company has also granted the underwriter a 45-day option to purchase up to 150,000 additional shares of common stock.
* The company also received approval to list its common stock on the Nasdaq Capital Market, with trading set to start on August 15, 2025.
MORE ON PROPANC BIOPHARMA, INC.
* Financial information for Propanc Biopharma, Inc. [https://seekingalpha.com/symbol/PPCB/income-statement]
Propanc Biopharma prices $4M stock offering
Published 2 months ago
Aug 15, 2025 at 8:11 AM
Positive
Auto